Palo Alto Medical Foundation Research Institute
Palo Alto, California, 94301, United States
NCT Number: NCT01479062
The trial will test whether the Alive multi-channel delivery health behavior program can positively affect weight and glucose level in pre-diabetics.
Looking for future studies?
Notify Me40 year–79 year
All sexes
Interventional
Not applicable
Palo Alto, California, 94301, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Weekly email/web goal-setting intervention to improve physical activity, diet and weight loss for pre-diabetics, with additional phone support
Placebo Control
Time frame: at 3 months, 6 months and one year
Mean weight loss and the proportion of subjects who achieve a 5% body weight loss at 3 and 6 months and maintain at 12 months
Time frame: at 3 months, 6 months and one year
Change in blood glucose level and hemoglobin A1c (HbA1c) as measured in clinic at 3 and 6 months and maintain at 12 months
Time frame: 3 months and 12 months
Extent of change in physical activity and dietary factors as reported in questionnaires
Berkeley Analytics, Inc.
Industry
Multi-Channel Automated Diet and Physical Activity Intervention for Pre-Diabetics (ALIVE-PD)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01647438
Behavior, Body Weight
Chicago, Illinois, United States
View Trial DetailsNCT04082585
Body Weight, Cardiovascular Diseases
Roseburg, Oregon, United States
View Trial DetailsNCT00233298
Body Weight, Diabetes
Baltimore, Maryland, United States
View Trial DetailsNCT05256615
Behavior, Diabete Mellitus
Edmonton, Alberta, Canada
View Trial Details